Journals / Turkish Journal of Medical Sciences / 2012 / Cilt: 42 - Sayı: 3

Skin prick test and immunotherapy in children with allergic eye disease

Pages
485–490
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Immunotherapy should be considered as a possible treatment option.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To investigate the necessity and efficacy of immunotherapy in children with allergic eye disease.
📊
Key Findings & Data:Materials and methods: The study included 57 patients with allergic eye disease who were followed by the Department of Ophthalmology and Department of Pediatrics at Adnan Menderes University Hospital.
💡
Conclusion & Impact:Immunotherapy should be considered as a possible treatment option.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Key words: Allergic agents · vernal keratoconjunctivitis · perennial allergic conjunctivitis

Abstract

To investigate the necessity and efficacy of immunotherapy in children with allergic eye disease. Materials and methods: The study included 57 patients with allergic eye disease who were followed by the Department of Ophthalmology and Department of Pediatrics at Adnan Menderes University Hospital. Blood and skin prick tests were carried out on 43 patients. Results: There were 38 male and 19 female patients with a mean age of 11 ± 4 years. The mean follow-up was 31 ± 3 months and 28 ± 4 months in 38 vernal keratoconjunctivitis (VKC) and 19 perennial allergic conjunctivitis (PAC) patients, respectively. Immunotherapy was administered to 8 (42%) PAC patients and 4 (17%) VKC patients. Patients that received immunotherapy did not need further medical treatment for their allergies. Conclusion: A skin prick test should be considered in the clinical evaluation of an allergic eye disease, especially if it is accompanied by other allergic diseases. Immunotherapy should be considered as a possible treatment option.

Özet

To investigate the necessity and efficacy of immunotherapy in children with allergic eye disease. Materials and methods: The study included 57 patients with allergic eye disease who were followed by the Department of Ophthalmology and Department of Pediatrics at Adnan Menderes University Hospital. Blood and skin prick tests were carried out on 43 patients. Results: There were 38 male and 19 female patients with a mean age of 11 ± 4 years. The mean follow-up was 31 ± 3 months and 28 ± 4 months in 38 vernal keratoconjunctivitis (VKC) and 19 perennial allergic conjunctivitis (PAC) patients, respectively. Immunotherapy was administered to 8 (42%) PAC patients and 4 (17%) VKC patients. Patients that received immunotherapy did not need further medical treatment for their allergies. Conclusion: A skin prick test should be considered in the clinical evaluation of an allergic eye disease, especially if it is accompanied by other allergic diseases. Immunotherapy should be considered as a possible treatment option.

🔖

Cite This Article

KOCATÜRK, T., ELİAÇIK, K., DAYANIR, V., KOCATÜRK, Ö. (2022). Skin prick test and immunotherapy in children with allergic eye disease. Turkish Journal of Medical Sciences, Cilt: 42 - Sayı: 3, 485–490. https://ajindex.com/articles/611200

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Abelson MB, Schaefer K. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv Ophthalmol 1993; 38: 115-32.
  2. Ross RN, Nelson HS, Finegold I. Eff ectiveness of specifi c immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, single or double-blind, placebo- controlled studies. Clin Th er 2000; 22: 329-41. 6. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy eff ective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151: 969-74.
  3. Chowdary VS, Vinaykumar EC, Rao JJ, Rao R, Babu KR, Rangamani V. A study on serum IgE and eosinophils in respiratory allergy patients. Indian J Allergy Asthma Immunol 2003; 17: 21-4.